RxDoctor Payments DataLook up a doctor →

KYMRIAH: payments to doctors

Payments that named KYMRIAH as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.2M
Providers
931
Transactions
2,620
Average per transaction
$474

The per-transaction average — $474 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 931 providers the average total is $1,334, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis$1,205,71997.0%
Novartis Pharma AG$36,6983.0%
← All drugs & devices